Latest News
Catch up on the latest blogs, press releases, publications, and other news at Indica Labs.

Versant Diagnostics Selects HALO AP® Platform to Deploy Digital Pathology Across a Network of Laboratories
Albuquerque, NM and Grapevine, TX, February 4, 2025 – Indica Labs, the global leader of AI-powered digital pathology and Versant Diagnostics, an independent physician services company and proponent of next-generation digital pathology, announce today that Versant Diagnostics has chosen the

Leica Biosystems and Indica Labs Announce Significant Strategic Investment and Creation of Digital Pathology Platform
Vista, CA, and Albuquerque, NM, January 8, 2025 – Leica Biosystems, a global leader in anatomic and digital pathology solutions, and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, today announced that Leica Biosystems has agreed

Molecular Pathology Laboratory Network, Inc. Selects HALO AP® to Deliver Comprehensive Reference Laboratory Services and Biopharma Laboratory Support
Albuquerque, NM, 19 December 2024 -Indica Labs announced today that Molecular Pathology Laboratory Network, Inc. (MPLN), a leader in laboratory medicine, hematopathology, and solid tumor oncology testing, has selected the HALO AP® platform from Indica Labs to deliver digital pathology

The Institute of Tissue Medicine of the University of Bern Chooses Indica Labs’ HALO AP® to Become the First Public Health Institute in Switzerland to Deploy Digital Pathology for Diagnostics in the Cloud with Amazon Web Services (AWS)
Albuquerque, NM, 11 December 2024 -Indica Labs, the global leader in AI-powered digital pathology, today announces that the Institute of Tissue Medicine and Pathology at the University of Bern, a leading university based pathology institute in Switzerland, has selected HALO
Fetal growth restriction (FGR) is a significant concern in obstetrics, affecting 5–10% of pregnancies globally. FGR is a major contributor to perinatal morbidity and mortality and poses a significant maternal risk due to potential co-occurrence with pre-eclampsia. Despite their impact,...
Learn MoreMelanoma, a highly aggressive type of skin cancer originating from pigment-producing cells called melanocytes, can be a source of diagnostic confusion for pathologists. While primary melanomas are easily recognizable, metastatic melanomas can dedifferentiate and exhibit varied and misleading cyto-architectural characteristics,...
Learn MoreHigh-grade serous ovarian cancer (HGSC) is known to have a high degree of both genetic and immunologic heterogeneity, can be resistant to chemotherapy, and commonly recurs in patients. It is also the most common form of ovarian cancer and represents...
Learn More
Open Pathology and AI Integrations: Empowering Labs with Choice
In digital pathology, advancements and proliferation in artificial intelligence (AI) and digital laboratory equipment are enabling streamlined workflows and new insights. However, they can also multiply the potential challenges laboratories face with software integration.

Announcing HALO® Vacuole, Object Colocalization BF, and Object Colocalization FL Modules Supporting Interactive Markups
We’re excited to announce the launch of the newly updated Vacuole, Object Colocalization BF, and Object Colocalization FL modules supporting interactive markups.

An interview with Dr. Peter Caie, Senior Principal Scientist, AI Diagnostics – Indica Labs
An interview with Dr. Peter Caie, Senior Principal Scientist, AI Diagnostics – Indica Labs

Looking Back: Reviewing 2024 at Indica Labs
As 2024 draws to a close, we at Indica Labs would like to thank the customers and collaborators who helped fill 2024 with exciting discoveries, events, and partnerships. It is a great honor to have played a part in customers’ contributions to scientific fields ranging from immuno-oncology to infectious disease,

Indica Labs Joins the AWS Partner Network
Albuquerque, NM, December 4, 2024 – Indica Labs, the global leader in AI-powered digital pathology software and services, announced today that they have joined the Amazon Web Services (AWS) Partner Network (APN). The APN is a global community of AWS Partners that leverage programs, expertise, and resources to build, market,

An interview with Todd Camp, Applications Specialist, Clinical – Indica Labs
An interview with Todd Camp, Applications Specialist, Clinical – Indica Labs

12 Years of Digital Pathology Innovation and What to Expect Next
Kate Lillard Tunstall discusses Indica Lab’s 12-year journey in digital pathology, the impact of AI, and the future of the industry

Indica Labs’ Boston HALO® User Group Meeting
15 May 2025 | Indica Labs is pleased to announce our Boston HALO® User Group Meeting at Le Méridien Boston Cambridge on May 15 from 9:30 am – 4 pm.

Open Pathology and AI Integrations: Empowering Labs with Choice
In digital pathology, advancements and proliferation in artificial intelligence (AI) and digital laboratory equipment are enabling streamlined workflows and new insights. However, they can also multiply the potential challenges laboratories face with software integration.

Announcing HALO® Vacuole, Object Colocalization BF, and Object Colocalization FL Modules Supporting Interactive Markups
We’re excited to announce the launch of the newly updated Vacuole, Object Colocalization BF, and Object Colocalization FL modules supporting interactive markups.

Versant Diagnostics Selects HALO AP® Platform to Deploy Digital Pathology Across a Network of Laboratories
Albuquerque, NM and Grapevine, TX, February 4, 2025 – Indica Labs, the global leader of AI-powered digital pathology and Versant Diagnostics, an independent physician services company and proponent of next-generation digital pathology, announce today that Versant Diagnostics has chosen the HALO AP® platform from Indica Labs to further support their

An interview with Dr. Peter Caie, Senior Principal Scientist, AI Diagnostics – Indica Labs
An interview with Dr. Peter Caie, Senior Principal Scientist, AI Diagnostics – Indica Labs

Leica Biosystems and Indica Labs Announce Significant Strategic Investment and Creation of Digital Pathology Platform
Vista, CA, and Albuquerque, NM, January 8, 2025 – Leica Biosystems, a global leader in anatomic and digital pathology solutions, and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, today announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs. This
Webinars and Events
Check out our upcoming and most popular webinars and events!

Masterclass: High Dimensional Analysis in HALO®
10 April 2025 | Learn about workflows for highly multiplexed image analysis, including in the new HALO High Dimensional Analysis module!

Indica Labs’ Boston HALO® User Group Meeting
15 May 2025 | Indica Labs is pleased to announce our Boston HALO® User Group Meeting at Le Méridien Boston Cambridge on May 15 from 9:30 am – 4 pm.

Image Management for Life Science and Discovery Applications
8 May 2025 | Learn the latest advancements in HALO Link!

Getting Started with Brightfield Image Analysis in HALO®
3 April 2025 | Join us for an introductory webinar on brightfield image analysis in HALO®, designed for beginners. We’ll walk through key digital pathology workflows, including singleplex, multiplex, and H&E image analysis. You’ll learn essential object detection methods for identifying cells, tissue structures, and regions of interest.

Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration
16 October 2022 | In this 1-hour workshop, Eric Runde, Chief Operating Officer at Indica Labs, will introduce Indica’s platforms, our collaborative approach to incorporating artificial intelligence (AI) into life science and clinical workflows, and the open pathology tools available to developers and industry partners. Dr. Peter Caie, Principal Scientist

Adoption of the HALO® Platform at Caris Life Sciences’ High Volume Digital Pathology Laboratory
17 October 2021 | In this one-hour pre-conference workshop, Indica Labs is pleased to host Dr. Matthew Oberley, Executive Medical Director at Caris Life Sciences, who will present a case study on deploying HALO AP® case management software in their high-volume, fully digital, anatomic pathology lab. Dr. Oberley will discuss

Masterclass Webinar: Intro to the HALO AI Toolbox
29 June 2023 | Join us for this 1-hour webinar to see a breakdown of the networks that make up HALO AI and applications suitable for each one.

Choosing The Right Foundation: Selecting And Deploying An Image Management System For Diagnostic Digital Pathology
18 May 2023 | In this 60-minute webinar, we will discuss considerations when selecting a digital pathology image management system for clinical diagnostics. In the first half of the event, we pose questions and suggest approaches that your group may adopt when evaluating diagnostic digital pathology platforms. A comprehensive Vendor

Transforming Pathology at Nottingham University Hospitals: Implementing Digital Pathology using HALO AP®
2 March 2023 | Learn about transformational change in how pathology services are delivered at Nottingham University Hospitals

HALO Prostate AI – A Tool for Automated Detection and Gleason Grading of Prostate Cancer
05 October 2022 | Join us for this 1-hour webinar to learn how to implement the HALO Prostate AI tool for prostate cancer detection and grading

Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration
16 October 2022 | In this 1-hour workshop, Eric Runde, Chief Operating Officer at Indica Labs, will introduce Indica’s platforms, our collaborative approach to incorporating artificial intelligence (AI) into life science and clinical workflows, and the open pathology tools available to developers and industry partners. Dr. Peter Caie, Principal Scientist

Adoption of the HALO® Platform at Caris Life Sciences’ High Volume Digital Pathology Laboratory
17 October 2021 | In this one-hour pre-conference workshop, Indica Labs is pleased to host Dr. Matthew Oberley, Executive Medical Director at Caris Life Sciences, who will present a case study on deploying HALO AP® case management software in their high-volume, fully digital, anatomic pathology lab. Dr. Oberley will discuss

Masterclass Webinar: Intro to the HALO AI Toolbox
29 June 2023 | Join us for this 1-hour webinar to see a breakdown of the networks that make up HALO AI and applications suitable for each one.

Choosing The Right Foundation: Selecting And Deploying An Image Management System For Diagnostic Digital Pathology
18 May 2023 | In this 60-minute webinar, we will discuss considerations when selecting a digital pathology image management system for clinical diagnostics. In the first half of the event, we pose questions and suggest approaches that your group may adopt when evaluating diagnostic digital pathology platforms. A comprehensive Vendor

Transforming Pathology at Nottingham University Hospitals: Implementing Digital Pathology using HALO AP®
2 March 2023 | Learn about transformational change in how pathology services are delivered at Nottingham University Hospitals

HALO Prostate AI – A Tool for Automated Detection and Gleason Grading of Prostate Cancer
05 October 2022 | Join us for this 1-hour webinar to learn how to implement the HALO Prostate AI tool for prostate cancer detection and grading
Present with Indica Labs
Interested in presenting your work using HALO software at an Indica Labs webinar or user group meeting? Fill out the form below!
You can also drop us an email at marketing@indicalab.com and let us know!